Skip to content
Disclosery

EXANE DERIVATIVES: KWEB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KWEB, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 29,461 KWEB shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 29,461 shares
    Change vs previous 13F +20,530 shares

    0.55% of the 13F portfolio, value $964,945.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,931 shares
    Change vs previous 13F -2,250 shares

    0.07% of the 13F portfolio, value $254,607.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 11,181 shares
    Change vs previous 13F -1,120 shares

    0.1% of the 13F portfolio, value $407,980.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 12,301 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $582,062.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).